Question 1

What is the catalog number for Custom ELISA testing for anthrax antibodies in animal and human samples (vaccinated or normal)?

Accepted Answer

The catalog number for Custom ELISA testing for anthrax antibodies in animal and human samples (vaccinated or normal) is 900-100-CUX.

Question 2

What sizes are available for Custom ELISA testing for anthrax antibodies in animal and human samples (vaccinated or normal)?

Accepted Answer

Custom ELISA testing for anthrax antibodies in animal and human samples (vaccinated or normal) is available in the following size(s): 1 Custom.

Question 3

Is Custom ELISA testing for anthrax antibodies in animal and human samples (vaccinated or normal) in stock?

Accepted Answer

Custom ELISA testing for anthrax antibodies in animal and human samples (vaccinated or normal) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

Question 5

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 6

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Custom ELISA testing for anthrax antibodies in animal and human samples (vaccinated or normal)

Product Specifications

CAS Number

Type

Frequently Asked Questions

Explore Other Products

Human Poliovirus Receptor/PVR Recombinant Rabbit monoclonal Antibody

RPIA Human qPCR Primer Pair (NM_144563)

KRTAP11-1 Human qPCR Primer Pair (NM_175858)

1-Propylamine-d3

p-Anisic Acid

Cdc42ep4 Mouse Gene Knockout Kit (CRISPR)